AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
PERINDOPRIL ERBUMINE
9 registrations across 3 African markets— 6 active
Markets with PERINDOPRIL ERBUMINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| CIPLA PERINDOPRIL 8 mg | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Apr 2026 |
| CIPLASYL 2 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Jul 2025 |
| PANOPRIST 4MG COMPRIME BOITE DE 30 | 🇨🇮Côte d'Ivoire | SANDOZ GMBH | expired | Dec 2018 |
| CIPLASYL 8 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Jan 1900 |
| CIPLA PERINDOPRIL 4 mg | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Jan 1900 |
| CIPLASYL 4 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Jan 1900 |
| PANOPRIST comprimé / 8 mg | 🇸🇳Senegal | SANDOZ GMBH | active | — |
| PANOPRIST comprimé / 4 mg | 🇸🇳Senegal | SANDOZ GMBH | active | — |
| PANOPRIST comprimé / 4 mg | 🇸🇳Senegal | SANDOZ GMBH | active | — |
PERINDOPRIL ERBUMINE in Africa — Regulatory Overview
PERINDOPRIL ERBUMINE is registered across 3 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Senegal, Côte d'Ivoire. AfricaRegulatory refreshes this data daily from official government sources.
Of the 9 registrations, 6 (67%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.